Palvella Therapeutics (PVLA) Return on Sales (2014 - 2024)

Palvella Therapeutics (PVLA) has 11 years of Return on Sales data on file, last reported at 0.01% in Q3 2024.

• On a quarterly basis, Return on Sales changed 0.0% year-over-year to 0.01% in Q3 2024; TTM through Sep 2024 was 0.01%, a 0.0% change from a year earlier, with the FY2023 full-year figure at 0.0%, up 241.0% from the prior year.
• Return on Sales for Q3 2024 stood at 0.01%, down from 0.0% in the prior quarter.
• Over the last five years, Return on Sales for PVLA reached as high as 0.04% in Q4 2020 and fell as low as 0.9% in Q4 2022.
• Historically, Return on Sales has averaged 0.15% across 5 years, with a median of 0.01% in 2021.
• Across the five-year window, Return on Sales sank 89 bps in 2022 and soared 85 bps in 2023, its largest moves.
• Year by year, Return on Sales stood at 0.04% in 2020, then tumbled by 137 bps to 0.01% in 2021, then sank by 6389 bps to 0.9% in 2022, then soared by 94 bps to 0.05% in 2023, then jumped by 90 bps to 0.01% in 2024.
• Per Business Quant data, the three most recent Return on Sales figures were 0.01% in Q3 2024, 0.0% in Q2 2024, and 0.48% in Q1 2024.